Chinese General Practice

    Next Articles

Advances in Influencing Factors and Prognostic Evaluation of Futile Recanalization after Endovascular Therapy for Acute Ischemic Stroke

  

  1. Department of Epidemiology, School of Public Health, Nanchang University/Jiangxi Provincial Key Laboratory of Disease Prevention and Public Health, Nanchang 330006, China
  • Contact: Kuang Jie, Associate professor; E-mail: kuangjie@ncu.edu.cn

急性缺血性脑卒中血管内治疗无效再通影响因素及预后评估的研究进展

  

  1. 330031 江西省南昌市,南昌大学公共卫生学院流行病学教研室 疾病预防与公共卫生江西省重点实验室
    罗田与刘祖婷为共同第一作者
  • 通讯作者: 况杰,副教授;E-mail:kuangjie@ncu.edu.cn
  • 基金资助:
    国家自然科学基金资助项目(82360667,82160645);江西省自然科学基金资助项目(20212BAB206091);国家大学生创新创业训练计划项目(202510403077)

Abstract: Despite recent advances in endovascular treatment (EVT) techniques that have significantly increased the recanalization rate in patients with acute ischemic stroke (AIS), the incidence of futile recanalization (FR) remains high. Specifically, approximately half of AIS patients who undergo EVT and achieve successful complete reperfusion still have unfavorable functional outcomes at 90 days. It must be emphasized that recanalization itself is not the treatment endpoint; rather, substantial improvement in patients' functional prognosis is the ultimate goal of EVT. To this end, this article presents a systematic review of the factors influencing FR, aiming to thoroughly dissect and identify the key determinants of FR, thereby providing a theoretical basis for exploring effective intervention strategies and therapeutic targets.

Key words: Acute ischemic stroke, Endovascular therapy, Futile recanalization, Risk factors, Prognostic evaluation

摘要: 尽管近年来血管内治疗(EVT)技术的进步显著提高了急性缺血性脑卒中(AIS)患者的血管再通率,但无效再通(FR)的发生率仍然居高不下,具体而言,约半数接受 EVT 并成功实现完全再灌注的AIS患者,其 90 d功能预后依然不佳。需要强调的是,血管再通本身并非治疗终点,实现患者功能预后的实质性改善才是EVT的最终目标。为此,本文围绕FR的影响因素及风险评估进行系统综述,旨在深入剖析并明确导致FR的关键因素,以期为探索有效的干预策略及治疗靶点提供理论依据。

关键词: 急性缺血性脑卒中, 血管内治疗, 无效再通, 影响因素, 预后评估

CLC Number: